| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/07/1998 | US5776899 Polypeptide and anti-HIV agent prepared therefrom |
| 07/07/1998 | US5776895 Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock |
| 07/07/1998 | US5776750 Amino acid sequences and polypeptides for hybridizing and genes |
| 07/07/1998 | US5776712 Methods and materials for the detection of Staphylococcus aureus |
| 07/07/1998 | US5776468 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A |
| 07/07/1998 | US5776462 Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat |
| 07/07/1998 | US5776455 Pharmaceutical formulations |
| 07/02/1998 | WO1998028607A1 Systems and methods for quantifying photoreactions in light activated materials |
| 07/02/1998 | WO1998028435A1 Plant clones containing elevated secondary metabolite levels |
| 07/02/1998 | WO1998028333A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 07/02/1998 | WO1998028330A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028329A1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028328A1 Cyclosporin derivative, its preparation and pharmaceutical compositions containing same |
| 07/02/1998 | WO1998028317A2 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | WO1998028316A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 07/02/1998 | WO1998028305A1 Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them |
| 07/02/1998 | WO1998028299A2 Imidazopyridazines |
| 07/02/1998 | WO1998028292A1 Novel piperidine containing compounds |
| 07/02/1998 | WO1998028027A1 Combatting infection in delivery systems |
| 07/02/1998 | WO1998028011A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin |
| 07/02/1998 | WO1998028005A1 Chlamydia vaccines |
| 07/02/1998 | WO1998028004A1 Hepatitis delta particle containing a fusion protein immunogen |
| 07/02/1998 | WO1998028003A1 Formulations of recombinant papillomavirus vaccines |
| 07/02/1998 | WO1998028000A1 Stabilizers for lyophilized vaccines |
| 07/02/1998 | WO1998027966A2 Encapsulated cells producing antibodies |
| 07/02/1998 | WO1998027805A1 Antimicrobial proteins |
| 07/02/1998 | WO1998014445A3 Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/02/1998 | CA2275964A1 Synthesis of nucleosides and polynucleotides |
| 07/02/1998 | CA2275896A1 Chlamydia vaccines |
| 07/02/1998 | CA2275601A1 Imidazopyridazines |
| 07/02/1998 | CA2275373A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin |
| 07/02/1998 | CA2275359A1 Novel erythromycin derivatives, method of preparation and application as medicines |
| 07/02/1998 | CA2274755A1 Stabilizers for lyophilized vaccines |
| 07/02/1998 | CA2274730A1 Antimicrobial proteins |
| 07/02/1998 | CA2244952A1 Systems and methods for quantifying photoreactions in light activated materials |
| 07/01/1998 | EP0850948A1 Propiophenone derivatives and process for preparing the same |
| 07/01/1998 | EP0850924A1 Aromatic diselenides and selenosulphides for use as antioxidant agents |
| 07/01/1998 | EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof |
| 07/01/1998 | EP0850319A1 Method for modulating cell apoptosis |
| 07/01/1998 | EP0850316A1 Cryptophycins from aberrant biosynthesis |
| 07/01/1998 | EP0850308A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 07/01/1998 | EP0850305A2 Compounds and methods for diagnosis of tuberculosis |
| 07/01/1998 | EP0850300A1 Method of modulating gene expression with reduced immunostimulatory response |
| 07/01/1998 | EP0850247A1 Pyrimidine nucleoside derivative |
| 07/01/1998 | EP0850246A2 Pyrimidine nucleoside derivatives |
| 07/01/1998 | EP0850240A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | EP0850071A1 Gene therapy for effector cell regulation |
| 07/01/1998 | EP0850063A1 Methods and compositions for treating fungal infections in mammals |
| 07/01/1998 | EP0850060A1 Zwitterionic forms of trovafloxacin |
| 07/01/1998 | EP0850059A1 Pharmaceutical formulations containing darifenacin |
| 07/01/1998 | EP0850057A1 Pharmaceutical compounds |
| 07/01/1998 | EP0640095B1 Process for making vancomycin |
| 07/01/1998 | EP0527906B1 Inhibition of influenza virus replication by oligonucleotides |
| 07/01/1998 | CN1186501A Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4 |
| 07/01/1998 | CN1186499A Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 07/01/1998 | CN1186495A Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 07/01/1998 | CN1186494A Antibacterial cephalosporins |
| 07/01/1998 | CN1186434A Pharmaceutical composition comprising proteinase inhibitor and monoglyceride |
| 07/01/1998 | CN1185947A Composition for treatng condyloma acuminata |
| 07/01/1998 | CN1038904C Preparation of megestrol acetate |
| 06/30/1998 | US5773610 Optically active 3-(1-(alkylamino))alkyl pyrrolidines |
| 06/30/1998 | US5773600 DNA encoding pertussis toxin muteins |
| 06/30/1998 | US5773581 Acid stable substance dervived from naturally occuring granulocyte colony stimulating factor |
| 06/30/1998 | US5773578 Polypeptides and proteins |
| 06/30/1998 | US5773571 Peptide nucleic acids |
| 06/30/1998 | US5773462 Biflavanoids and derivatives thereof as antiviral agents |
| 06/30/1998 | US5773451 Bactericides for helicobacter bacteria |
| 06/30/1998 | US5773446 Diamino pyrimidines |
| 06/30/1998 | US5773443 Triazole antifungal agents |
| 06/30/1998 | US5773421 Antifungal fusacandins |
| 06/30/1998 | US5773263 Production aflastatin A from streptomyces sp., a pharmaceutical composition and methods of use |
| 06/30/1998 | US5773260 Ribozyme compositions and expression vectors |
| 06/30/1998 | US5773235 Equine arteritis virus peptides; antibodies and their use in a diagnostic test |
| 06/30/1998 | US5773230 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 06/30/1998 | US5773027 Liposomes encapsulating antiviral drugs |
| 06/30/1998 | US5773000 Therapeutic treatment of clostridium difficile associated diseases |
| 06/30/1998 | US5772999 Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals |
| 06/30/1998 | US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 06/30/1998 | CA2239926A1 N-linked sulfonamides of heterocyclic thioesters |
| 06/30/1998 | CA2040548C Use of autologous promoters to express gene products in bordetella |
| 06/30/1998 | CA2004197C Ab-021 antibiotics and process for producing them |
| 06/30/1998 | CA1339936C Animal interferons |
| 06/25/1998 | WO1998027215A1 Live recombinant avian vaccine, using the infectious laryngotracheitis avian virus as vector |
| 06/25/1998 | WO1998027098A1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 06/25/1998 | WO1998027094A1 Ethylidene derivatives of tricyclic carbapenems |
| 06/25/1998 | WO1998027073A1 Asymmetric synthesis of benzoxazinones |
| 06/25/1998 | WO1998026800A1 In ovo vaccination against newcastle disease |
| 06/25/1998 | WO1998026794A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 06/25/1998 | WO1998026788A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 06/25/1998 | WO1998026779A1 The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of helicobacter pylori infections and associated gastroduodenal diseases |
| 06/25/1998 | WO1998026768A2 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
| 06/25/1998 | WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 06/25/1998 | WO1998011887A3 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 06/25/1998 | WO1998001154A3 Treatment and diagnosis of infections of gram positive cocci |
| 06/25/1998 | CA2275213A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 06/25/1998 | CA2274892A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections andthe gastroduodenal diseases associated therewith |
| 06/24/1998 | EP0849269A1 Vinyl pyrrolidine cephalosporins with basic substituents |
| 06/24/1998 | EP0848956A1 In ovo vaccination against Newcastle Disease |
| 06/24/1998 | EP0848758A1 Targeted nucleotide sequence delivery and integration system |